lekaren slovenska 24<\/a>, ktor\u00e9 pom\u00e1haj\u00fa zabezpe\u010di\u0165 dodr\u017eiavanie regul\u00e1ci\u00ed. Zabezpe\u010di\u0165 dodr\u017eiavanie t\u00fdchto regul\u00e1ci\u00ed je k\u013e\u00fa\u010dov\u00e9 pre ochranu zdravia pacientov a z\u00e1rove\u0148 pre zabezpe\u010denie konkurencieschopnosti spolo\u010dnost\u00ed na trhu.<\/p>\nRegula\u010dn\u00e9 r\u00e1mce sa l\u00ed\u0161ia v z\u00e1vislosti od krajiny a regi\u00f3nu, \u010do m\u00f4\u017ee predstavova\u0165 dodato\u010dn\u00e9 prek\u00e1\u017eky pre farmaceutick\u00e9 firmy, najm\u00e4 tie, ktor\u00e9 p\u00f4sobia na medzin\u00e1rodnej \u00farovni. Tieto firmy musia investova\u0165 do odborn\u00fdch znalost\u00ed, aby dok\u00e1zali navigova\u0165 medzi r\u00f4znymi normami a predpismi, a to m\u00f4\u017ee vies\u0165 k zna\u010dn\u00fdm n\u00e1kladom a \u010dasov\u00fdm oneskoreniam.<\/p>\n
Hlavn\u00e9 regula\u010dn\u00e9 po\u017eiadavky<\/h3>\n
Medzi najd\u00f4le\u017eitej\u0161ie regula\u010dn\u00e9 po\u017eiadavky patr\u00ed schva\u013eovanie liekov, klinick\u00e9 sk\u00fa\u0161ania a bezpe\u010dnostn\u00e9 monitorovanie. Ka\u017ed\u00fd nov\u00fd liek mus\u00ed prejs\u0165 rozsiahlymi testovaniami, aby sa zabezpe\u010dila jeho \u00fa\u010dinnos\u0165 a bezpe\u010dnos\u0165 pred uveden\u00edm na trh. Tieto procesy m\u00f4\u017eu trva\u0165 nieko\u013eko rokov, \u010do m\u00f4\u017ee spomali\u0165 inov\u00e1cie v oblasti farm\u00e1cie.<\/p>\n
Okrem toho musia farmaceutick\u00e9 firmy dodr\u017eiava\u0165 pravidl\u00e1 o ozna\u010dovan\u00ed a reklame, aby sa zabezpe\u010dilo, \u017ee spotrebitelia bud\u00fa ma\u0165 pr\u00edstup k presn\u00fdm a transparentn\u00fdm inform\u00e1ci\u00e1m o liekoch. Tieto regul\u00e1cie s\u00fa navrhnut\u00e9 tak, aby chr\u00e1nili pacientov pred zav\u00e1dzaj\u00facimi inform\u00e1ciami, ale z\u00e1rove\u0148 m\u00f4\u017eu obmedzi\u0165 marketingov\u00e9 aktivity spolo\u010dnost\u00ed.<\/p>\n
Pr\u00edstupy k prekonaniu regula\u010dn\u00fdch prek\u00e1\u017eok<\/h3>\n
Farmaceutick\u00e9 firmy m\u00f4\u017eu vyu\u017ei\u0165 nieko\u013eko strat\u00e9gi\u00ed na prekonanie regula\u010dn\u00fdch prek\u00e1\u017eok. Prv\u00fdm krokom je investovanie do vzdel\u00e1vania a \u0161kolen\u00ed zamestnancov, aby si boli vedom\u00ed aktu\u00e1lnych legislat\u00edvnych zmien a po\u017eiadaviek. T\u00fdmto sp\u00f4sobom m\u00f4\u017eu firmy zabezpe\u010di\u0165, \u017ee ich procesy a produkty bud\u00fa v s\u00falade s platn\u00fdmi regul\u00e1ciami.<\/p>\n
Druhou strat\u00e9giou je spolupr\u00e1ca s regula\u010dn\u00fdmi org\u00e1nmi a odborn\u00edkmi v oblasti pr\u00e1va. Odborn\u00e9 poradenstvo m\u00f4\u017ee pom\u00f4c\u0165 firm\u00e1m efekt\u00edvne navigova\u0165 zlo\u017eit\u00fdmi predpismi a minimalizova\u0165 riziko ch\u00fdb, ktor\u00e9 by mohli vies\u0165 k pokut\u00e1m alebo in\u00fdm sankci\u00e1m.<\/p>\n
Vyu\u017eitie technol\u00f3gie na zlep\u0161enie s\u00faladu s regul\u00e1ciami<\/h3>\n
Technol\u00f3gie hraj\u00fa d\u00f4le\u017eit\u00fa \u00falohu pri zjednodu\u0161en\u00ed procesov a zlep\u0161en\u00ed s\u00faladu s regula\u010dn\u00fdmi po\u017eiadavkami. Implement\u00e1cia syst\u00e9mov pre spr\u00e1vu dokumentov a elektronick\u00fdch datab\u00e1z m\u00f4\u017ee pom\u00f4c\u0165 farmaceutick\u00fdm firm\u00e1m sledova\u0165 a riadi\u0165 procesy s\u00favisiace s regul\u00e1ciami efekt\u00edvnej\u0161ie.<\/p>\n
Okrem toho m\u00f4\u017eu modern\u00e9 n\u00e1stroje na anal\u00fdzu d\u00e1t umo\u017eni\u0165 firm\u00e1m r\u00fdchlej\u0161ie identifikova\u0165 a reagova\u0165 na zmeny v legislat\u00edve. To m\u00f4\u017ee vies\u0165 k v\u00e4\u010d\u0161ej flexibilite a r\u00fdchlej\u0161iemu prisp\u00f4sobeniu sa nov\u00fdm po\u017eiadavk\u00e1m, \u010do je pre firmy nesmierne d\u00f4le\u017eit\u00e9 v dynamickom prostred\u00ed farm\u00e1cie.<\/p>\n
Inform\u00e1cie a zdroje na podporu farmaceutick\u00fdch spolo\u010dnost\u00ed<\/h3>\n
Na internete s\u00fa dostupn\u00e9 r\u00f4zne zdroje a platformy, ktor\u00e9 pon\u00fakaj\u00fa potrebn\u00e9 inform\u00e1cie o regula\u010dn\u00fdch v\u00fdzvach v oblasti farm\u00e1cie. Tieto zdroje m\u00f4\u017eu obsahova\u0165 odborn\u00e9 \u010dl\u00e1nky, webin\u00e1re a pr\u00edpadov\u00e9 \u0161t\u00fadie, ktor\u00e9 pom\u00e1haj\u00fa firm\u00e1m lep\u0161ie porozumie\u0165 aktu\u00e1lnym trendom a v\u00fdzvam.<\/p>\n
Firmy by mali vyh\u013ead\u00e1va\u0165 platformy, ktor\u00e9 pon\u00fakaj\u00fa poradenstvo a \u0161kolenia v oblasti dodr\u017eiavania regul\u00e1ci\u00ed. Tak\u00e9to slu\u017eby im m\u00f4\u017eu poskytn\u00fa\u0165 potrebn\u00e9 znalosti a n\u00e1stroje na prekonanie regula\u010dn\u00fdch prek\u00e1\u017eok a posilnenie ich postavenia na trhu.<\/p>\n","protected":false},"excerpt":{"rendered":"
Regula\u010dn\u00e9 v\u00fdzvy v oblasti farm\u00e1cie Ako ich prekona\u0165 \u00davod do regula\u010dn\u00fdch v\u00fdziev v oblasti farm\u00e1cie Farmaceutick\u00fd priemysel \u010del\u00ed mnoh\u00fdm regula\u010dn\u00fdm v\u00fdzvam, ktor\u00e9 ovplyv\u0148uj\u00fa v\u00fdrobu, distrib\u00faciu a marketing liekov. Tieto v\u00fdzvy zah\u0155\u0148aj\u00fa zlo\u017eit\u00fa legislat\u00edvu, ktor\u00fa je potrebn\u00e9 dodr\u017eiava\u0165, ako aj neust\u00e1le sa meniacie predpisy a normy. Je d\u00f4le\u017eit\u00e9, aby farmaceutick\u00e9 firmy vedeli, kde n\u00e1jdu efekt\u00edvne inform\u00e1cie, […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3],"tags":[],"class_list":["post-22980","post","type-post","status-publish","format-standard","hentry","category-public"],"_links":{"self":[{"href":"http:\/\/haywire.pl\/index.php?rest_route=\/wp\/v2\/posts\/22980","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/haywire.pl\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/haywire.pl\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/haywire.pl\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/haywire.pl\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=22980"}],"version-history":[{"count":1,"href":"http:\/\/haywire.pl\/index.php?rest_route=\/wp\/v2\/posts\/22980\/revisions"}],"predecessor-version":[{"id":22981,"href":"http:\/\/haywire.pl\/index.php?rest_route=\/wp\/v2\/posts\/22980\/revisions\/22981"}],"wp:attachment":[{"href":"http:\/\/haywire.pl\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=22980"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/haywire.pl\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=22980"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/haywire.pl\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=22980"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}